openPR Logo
Press release

Blepharitis Treatment Market Outlook and Opportunities in Grooming Regions Appraised By Global Players Scope Ophthalmic Ltd, NovaBay Pharmaceuticals Inc, Thea Pharmaceuticals Ltd.

07-11-2019 02:28 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Blepharitis Treatment Market

Blepharitis Treatment Market

Blepharitis Treatment Market Key Players:-

Key players operating in the Blepharitis treatment market include Scope Ophthalmic Ltd, NovaBay Pharmaceuticals Inc, Thea Pharmaceuticals Ltd, Perrigo Laboratories, InSite Vision Incorporated, Merck & Co, and Novartis AG

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/1761

Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of skin around the eyes, crusted eyelashes after waking up, more frequent blinking, abnormal growth of eyelashes, and stinging sensation in the eyes. Blepharitis causes seborrheic dermatitis, which is dandruff of the eyebrows and scalp, bacterial infection, clogged oil glands, malfunctioning of oil glands, rosacea. It also causes allergic reactions to eye medications, contact lens solutions or eye make-up and eyelash lice or mites.

Blepharitis Treatment Market Drivers:-

The blepharitis treatment market is expected to witness significant grow due to growing prevalence of ophthalmic disorders among the geriatric population. According to a survey conducted by American Academy of Ophthalmology in 2014, blepharitis usually affects people above the age of 50 years. It also states that blepharitis is observed in 37% male ophthalmic patients and 47% in female ophthalmic patients. Blepharitis market is also expected to grow due to increasing number of drugs in the pipeline. For instance, ISV-305 sponsored by InSite Vision is in phase 3 clinical trials, ISV-305 treats patients with early symptoms of blepharitis.

Furthermore, new product launches and mergers and acquisitions over the recent past also contributes to market growth. For instance, in 2015, BlephEx, a Franklin-based company launched Rysurg. It is used to clean eyelids and also maintains hygiene. According to a study conducted by American Academy of Ophthalmology in 2015 around 50% of ophthalmic patients suffer from symptoms of blepharitis and dry eyes. Constant use of this device helps prevent recurrence of blephairis and the treatment is pain-free. In 2013, Shire Plc, purchased Californian Ophthalmic Company SARcode Bioscience to add new drug lifitegrast to Shire’s specialist drug portfolio. Lifitegrast was approved by the FDA for the treatment of signs and symptoms of dry eye and blepharitis in 2016.

Factors hampering growth of blepharitis market include lack of awareness regarding treatment of this chronic condition and high cost of the medication required to treat blepharitis.

Blepharitis Treatment Market Regional Analysis:-

North America Blepharitis treatment market is expected to hold dominant position due to increasing geriatric population, launch of new products, and increasing number of ophthalmic patients in the region. According to a survey conducted in the U.S., by Population Reference Bureau in 2016, states that the aging population increased by 24% as compared to 15% in 2014. Europe is expected to witness rapid growth due to new product launches of blepharitis drugs in the region. For instance, in 2017, Scope Ophthalmic launched Moist Heat Mask, a device that helps in the treatment of blepharitis by loosening the oil present in Meibomian glands and allowing it to flow more freely. It helps to soften eye lash debris, prevent the evaporation of natural tear film, restores moisture to the eye and also the surrounding area, as well as improves tear film lipid quality. In 2015, MiBo Medical Group, a U.S.-based company, launched MibO Thermoflo. This device helps in the treatment of blepharitis and dry eyes and is required to be gently massaged on the margins of the eyelids for a minimum of 12 minutes. In 2015, MiBo Medical Group launched Lid Pro, a device that is used to treat anterior Blepharitis. The region of Asia Pacific is expected to witness significant growth due to increasing prevalence of blepharitis. According to a study conducted by Journal of Clinical and Experimental Ophthalmology in 2016, signs and symptoms of blepharitis increased by 32% among the geriatric population as compared to 2014.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1761

Blepharitis Treatment Market Taxonomy:-

The global Blepharitis treatment market is segmented based on disease type, treatment type, distribution channel, and region.

By Disease Type:-

Posterior Blepharitis
Anterior Blepharitis
Mixed Blepharitis

By Treatment Type:-

Antibiotic Therapy
Topical Corticosteroids
Topical Antibodies
Oral Antibodies
Ointments
Eye Cleansers
Others

By Distribution Channel:-

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:-

North America
Europe
Latin America
Asia-Pacific
Middle East
Africa

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blepharitis Treatment Market Outlook and Opportunities in Grooming Regions Appraised By Global Players Scope Ophthalmic Ltd, NovaBay Pharmaceuticals Inc, Thea Pharmaceuticals Ltd. here

News-ID: 1802104 • Views: 357

More Releases from Coherent Market Insights

Surgical Tourniquets Market Analysis By Industry Value with top key players Anet …
A compression bandage could be a pressure or constricting device accustomed to management blood vessel and blood vessel circulation for a protracted amount of your time. Major quantity of blood is lost in things like open surgeries performed on patients with serious affliction or accidents. Surgical tourniquets are majorly utilized in plastic surgeries and orthopedic surgeries. Surgical tourniquets stop blood flow to a specific limb, enabling surgeons to figure with
Immunoglobulin Market Development and Trends Forecasts with top key players Baxt …
Immunoglobulins area unit vital a part of the immune reaction, that specifically acknowledge and bind to explicitantigens like microorganism or viruses aiding in their inhibition. Immunoglobulins are conjointly known as antibodies area unit the conjugated protein molecules created by plasma cells i.e. white blood cells. The protein immune reaction is very advanced and extremely specific. the assorted immune serum globulin categories and subclasses (isotypes) disagree in their biological options, structure,
𝐈𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐑𝐨𝐛𝐨𝐭𝐢𝐜𝐬 𝐌 …
Report on the Inspection Robotics Market 2018 highlights the detailed study of market containing production, overview, dimensions, producers, value, price, income, deals, growth rate, consumption, export, import, sales revenue, supply, future plans and the technological developments for the comprehensive analysis of the Inspection Robotics Market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗖𝗼𝗽𝘆 @ https://www.coherentmarketinsights.com/insight/request-pdf/604 Robots have found extensive applications for automating several repetitive industrial tasks. In conjunction with the development in the robotic vision systems
Bug Tracking Software Market Latest Innovation, Advance Technology
The Bug Tracking Software Market research report is recently released to offer extensive evaluations based on structure, potential, scope, growth prospects, and fluctuations in the market. The report primarily aims to assess market size, share, profitability, revenue, and growth rates at a minute level to provide inclusive comprehension of Bug Tracking Software market performance. The report covers wide-ranging occurrences covering the historical, present, and futuristic sitch of the market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙

All 5 Releases


More Releases for Blepharitis

Blepharitis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results
Blepharitis is an inflammatory disorder of eyelids and can be categorized into two types; anterior and posterior blepharitis. The inflammation at the outside front of the eyelid is anterior blepharitis, whereas, inflammation at the inner eyelid is posterior blepharitis. Download the sample report @ https://www.pharmaproff.com/request-sample/1055 The major complications associated with blepharitis are the sty (acute infection of oil glands in eye), chalazion (painless lump due to inflammation of oil glands in eye),
Blepharitis Market Competitive Healthcare Assessment 2018 to 2025
Global Blepharitis Market Research Report 2018 tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Blepharitis market. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different
Blepharitis Treatment Market Trends, Outlook, and Opportunity Analysis, 2018-202 …
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Treatment Market Opportunity Analysis, 2018-2026
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Market Display Significant Growth by 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly
Blepharitis Market Projected to be Resilient During 2017 - 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly